Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Preferred Stock Liabilities (2019 - 2022)

Historic Preferred Stock Liabilities for Korro Bio (KRRO) over the last 2 years, with Q4 2022 value amounting to $77.7 million.

  • Korro Bio's Preferred Stock Liabilities changed N/A to $77.7 million in Q4 2022 from the same period last year, while for Dec 2022 it was $77.7 million, marking a year-over-year change of. This contributed to the annual value of $77.7 million for FY2022, which is N/A changed from last year.
  • Per Korro Bio's latest filing, its Preferred Stock Liabilities stood at $77.7 million for Q4 2022.
  • Korro Bio's 5-year Preferred Stock Liabilities high stood at $147.9 million for Q3 2019, and its period low was $77.7 million during Q4 2022.